Antibe Therapeutics Inc (ATBPF)
0.2156
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Antibe Therapeutics 1 Year Total Returns (Daily): -46.38% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | -46.38% |
| May 03, 2024 | -46.38% |
| May 02, 2024 | -46.38% |
| May 01, 2024 | -46.38% |
| April 30, 2024 | -46.38% |
| April 29, 2024 | -46.38% |
| April 26, 2024 | -44.72% |
| April 25, 2024 | -45.91% |
| April 24, 2024 | -43.52% |
| April 23, 2024 | -45.77% |
| April 22, 2024 | -45.77% |
| April 19, 2024 | -45.77% |
| April 18, 2024 | -45.77% |
| April 17, 2024 | -45.77% |
| April 16, 2024 | -46.07% |
| April 15, 2024 | -46.07% |
| April 12, 2024 | -46.07% |
| April 11, 2024 | -47.16% |
| April 10, 2024 | -49.08% |
| April 09, 2024 | -50.12% |
| April 08, 2024 | -50.12% |
| April 05, 2024 | -56.75% |
| April 04, 2024 | -52.52% |
| April 03, 2024 | -55.80% |
| April 02, 2024 | -69.09% |
| Date | Value |
|---|---|
| April 01, 2024 | -73.75% |
| March 28, 2024 | -28.94% |
| March 27, 2024 | -26.50% |
| March 26, 2024 | -26.42% |
| March 25, 2024 | -29.45% |
| March 22, 2024 | -32.39% |
| March 21, 2024 | -22.34% |
| March 20, 2024 | -20.42% |
| March 19, 2024 | -19.89% |
| March 18, 2024 | -16.30% |
| March 15, 2024 | -13.75% |
| March 14, 2024 | -8.08% |
| March 13, 2024 | 2.26% |
| March 12, 2024 | -6.39% |
| March 11, 2024 | -12.57% |
| March 08, 2024 | -13.06% |
| March 07, 2024 | 2.82% |
| March 06, 2024 | 2.32% |
| March 05, 2024 | 3.68% |
| March 04, 2024 | 2.06% |
| March 01, 2024 | 89.92% |
| February 29, 2024 | 91.63% |
| February 28, 2024 | 92.60% |
| February 27, 2024 | 104.8% |
| February 26, 2024 | 98.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.58%
Minimum
Feb 17 2022
161.0%
Maximum
Feb 07 2020
-10.31%
Average
-19.12%
Median
1 Year Total Returns (Daily) Benchmarks
| Acasti Pharma Inc | 9.80% |
| Aurinia Pharmaceuticals Inc | -55.36% |
| Edesa Biotech Inc | -38.27% |
| Lexaria Bioscience Corp | 158.8% |
| InMed Pharmaceuticals Inc | -79.20% |